Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results - Ferrarotto, R; Bell, D; Rubin, M L (Clin Cancer Res, 2020)